BEAST 2: A Software Platform for Bayesian Evolutionary Analysis
We present a new open source, extensible and flexible software platform for Bayesian evolutionary analysis called BEAST 2. This software platform is a re-design of the popular B...
Publications
Explore 662 academic publications
Showing 12 of
662 publications
Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions
On a shelf in the sunny, open‐plan office of Cochrane Australia in Melbourne, there's a large, white ring‐binder that, it's fair to say, hasn't been opened in a while. It's a pr...
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
The gene-expression profile we studied is a more powerful predictor of the outcome of disease in young patients with breast cancer than standard systems based on clinical and hi...
Attention Is All You Need
The dominant sequence transduction models are based on complex recurrent or convolutional neural networks in an encoder-decoder configuration. The best performing models also co...
Video Google: a text retrieval approach to object matching in videos
We describe an approach to object and scene retrieval which searches for and localizes all the occurrences of a user outlined object in a video. The object is represented by a s...
The Astropy Project: Building an Open-science Project and Status of the v2.0 Core Package<sup>*</sup>
Abstract The Astropy Project supports and fosters the development of open-source and openly developed Python packages that provide commonly needed functionality to the astronomi...
Spreading Dead Zones and Consequences for Marine Ecosystems
Dead zones in the coastal oceans have spread exponentially since the 1960s and have serious consequences for ecosystem functioning. The formation of dead zones has been exacerba...
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Pembrolizumab had an acceptable side-effect profile and showed antitumor activity in patients with advanced non-small-cell lung cancer. PD-L1 expression in at least 50% of tumor...